Our previous study demonstrated that FGF21‐knockout (FGF21‐KO) mice are more prone to develop diabetic cardiomyopathy,12 which can be reversed by the administration of recombinant human FGF21.13 Here, FGF21 is linked to diabetic cardiomyopathy.